Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies vorinostat in treating patients with stage IV breast cancer
receiving hormone therapy. Vorinostat may help hormone therapy work better by making tumor
cells more sensitive to the drug.